Mono Pharmacare Appoints Nirmala Ranawat as Additional Independent Director
The Board of Directors of Mono Pharmacare Limited has appointed Ms. Nirmala Ranawat as an Additional Director, holding both Non-Executive and Independent status on the company's board. The appointment was formalized on June 3, 2026.Ms. Ranawat is set to hold office for a term up to five consecutive years, effective from the date of her appointment, subject to approval by the members at an ensuing General Meeting.
The appointment comes as part of corporate governance developments at Mono Pharmacare Limited. Ms. Nirmala Ranawat has been confirmed as having no debarment status from holding directorial office by any regulatory authority.
Director Profile and Expertise
Ms. Nirmala Ranawat brings extensive experience in Corporate Laws, GST & Taxation, Audit, Financial Management, and Regulatory Compliance to her new role. She is a Practicing Company Secretary (FCS) and possesses strong multidisciplinary expertise, holding qualifications including FCS (ICSI), M.Com., LL.B., and CA-IPCC (with completed Articleship).She is the founder of M/s Nirmala Ranawat & Associates, a professional firm established in 2018 that provides comprehensive advisory and compliance services to corporate entities, startups, and SMEs. Her specialization includes GST consultancy, financial advisory, taxation, audit support, due diligence, and regulatory matters.
In addition to her entrepreneurial venture, Ms. Ranawat serves as a Director at Governsphere India Private Limited and Wise Monkey Advisory Private Limited. She has also been associated with the Institute of Law, Nirma University since February 2025, contributing to legal and management education.
Key details regarding the appointment are summarized in the table below:
| Detail | Information |
|---|---|
| Role | Additional Director (Non-Executive & Independent) |
| Date of Appointment | June 3, 2026 |
| Term | Up to 5 consecutive years (Subject to members' approval) |
| Professional Credentials | FCS, M.Com., LL.B., CA-IPCC |
| Current Affiliations | Founder of M/s Nirmala Ranawat & Associates; Director at Governsphere India Pvt. Ltd and Wise Monkey Advisory Pvt. Ltd. |
MONOPHARMA Stock Price Movement
Shares of Mono Pharmacare Limited slipped sharply, shedding 5.00% to settle at ₹11.4 today. The stock saw a limited trading volume of 4,000 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.